[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Livanova Plc OR Sh (LIVN)

Livanova Plc OR Sh (LIVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,054,129
  • Shares Outstanding, K 54,934
  • Annual Sales, $ 1,388 M
  • Annual Income, $ -242,470 K
  • EBIT $ 192 M
  • EBITDA $ 275 M
  • 60-Month Beta 0.82
  • Price/Sales 2.89
  • Price/Cash Flow 15.10
  • Price/Book 3.31

Options Overview Details

View History
  • Implied Volatility 41.52% (+0.67%)
  • Historical Volatility 53.94%
  • IV Percentile 32%
  • IV Rank 34.62%
  • IV High 64.37% on 07/16/25
  • IV Low 29.42% on 05/15/26
  • Expected Move (DTE 16) 5.87 (7.96%)
  • Put/Call Vol Ratio 1.50
  • Today's Volume 20
  • Volume Avg (30-Day) 92
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 227
  • Open Int (30-Day) 819
  • Expected Range 67.94 to 79.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.95
  • Number of Estimates 2
  • High Estimate $0.96
  • Low Estimate $0.94
  • Prior Year $0.93
  • Growth Rate Est. (year over year) +2.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.44 +30.78%
on 05/05/26
75.82 -2.64%
on 05/26/26
+12.81 (+21.00%)
since 05/01/26
3-Month
56.44 +30.78%
on 05/05/26
75.82 -2.64%
on 05/26/26
+3.21 (+4.55%)
since 02/27/26
52-Week
41.01 +79.96%
on 08/01/25
75.82 -2.64%
on 05/26/26
+30.56 (+70.66%)
since 05/30/25

Most Recent Stories

More News
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Stefano Folli will join the Company as incoming President, Cardiopulmonary (CP), effective June 1, succeeding...

LIVN : 73.81 (+0.01%)
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the Goldman Sachs 47 th Annual Global Healthcare Conference in Miami Beach, Fla....

LIVN : 73.81 (+0.01%)
LivaNova: Q1 Earnings Snapshot

LivaNova: Q1 Earnings Snapshot

LIVN : 73.81 (+0.01%)
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

– Delivered double-digit reported and constant-currency revenue growth – Raised full-year 2026 revenue and adjusted diluted earnings per share guidance...

LIVN : 73.81 (+0.01%)
Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea

– Study demonstrates proximal hypoglossal nerve stimulation (pHGNS) yielded clinically significant responses and sustained improvements over time – First rigorous...

LIVN : 73.81 (+0.01%)
LivaNova to Announce First-Quarter 2026 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2026 results on Wed., May 6, 2026, at 1 p.m. London time (8 a.m. Eastern...

LIVN : 73.81 (+0.01%)
LivaNova to Announce First-Quarter 2026 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2026 results on Wed., May 6, 2026, at 1 p.m. London time (8 a.m. Eastern...

LIVN : 73.81 (+0.01%)
LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

– First and only hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning language – Next-generation,...

LIVN : 73.81 (+0.01%)
LivaNova: Q4 Earnings Snapshot

LivaNova: Q4 Earnings Snapshot

LIVN : 73.81 (+0.01%)
LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance

– Delivered double-digit reported and organic revenue growth and continued operating margin expansion for full-year 2025 – Issued full-year 2026 guidance,...

LIVN : 73.81 (+0.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London,...

See More

Key Turning Points

3rd Resistance Point 76.70
2nd Resistance Point 75.49
1st Resistance Point 74.65
Last Price 73.81
1st Support Level 72.60
2nd Support Level 71.40
3rd Support Level 70.56

See More

52-Week High 75.82
Last Price 73.81
Fibonacci 61.8% 62.52
Fibonacci 50% 58.42
Fibonacci 38.2% 54.31
52-Week Low 41.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.